CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 195 enrolled
Drug / intervention
Promoting Resilience in Stress Management (PRISM)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03668223
NCT03668223N/ACompleted
CompareCT.gov

The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advanced Cancer

Dana-Farber Cancer Institute·interventional·Posted Sep 12, 2018·Updated Dec 5, 2025

In Brief

A clinical study evaluating Promoting Resilience in Stress Management (PRISM) for Cancer and 6 related conditions. Completed, enrolled 195 participants across 5 sites.

Detailed Summary

Multi-Site Randomized Controlled Trial testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults with Advanced Cancer

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer, Quality of Life, Anxiety, Depression, Hope, Coping Skills, Communication
CountriesUnited States
CollaboratorsChildren's Hospital Los Angeles, Baylor College of Medicine, University of Pittsburgh Medical Center, Seattle Children's Hospital, National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 12, 2018
Enrollment StartApr 15, 2019
Primary CompletionJan 23, 2024
Study CompletionOct 31, 2025
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 7.8 years ago

Interventions

Promoting Resilience in Stress Management (PRISM)behavioral

Manualized skills training targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making